Marlan D. Walker - 21 Feb 2023 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Chief Executive Officer
Signature
/s/ Marlan D. Walker
Issuer symbol
TXMD
Transactions as of
21 Feb 2023
Net transactions value
$0
Form type
4
Filing time
23 Feb 2023, 16:16:08 UTC
Previous filing
13 Feb 2023
Next filing
04 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Award $0 +70,000 $0.000000 70,000 21 Feb 2023 Common Stock 70,000 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in full on June 30, 2023.